NAD⁺ & Glutathione in Longevity: Roles, Evidence, and Synergy

by Dr.James Ross 

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

Aging is inevitable, but growing evidence suggests its pace can be influenced at the cellular level. Two molecules are central to this conversation: nicotinamide adenine dinucleotide (NAD⁺)—a coenzyme essential for energy metabolism and DNA repair—and glutathione (GSH)—the body’s predominant intracellular antioxidant. Both decline with age, compromising cellular resilience. This article outlines what NAD⁺ and GSH do, why they matter for healthy aging, how they reinforce each other, and what current research shows about supporting their levels.

NAD⁺: Cellular Power and Maintenance

What it is. NAD⁺ is present in every cell and cycles between NAD⁺ and NADH to shuttle electrons that drive ATP production across glycolysis, the TCA cycle, and oxidative phosphorylation.

Why it matters with age. Beyond metabolism, NAD⁺ fuels sirtuins and PARPs—enzymes tied to stress resistance, genomic stability, and repair. With age, NAD⁺ levels drop due to increased consumption (e.g., CD38 upregulation, PARP activation from accumulating DNA damage) and reduced synthesis. Low NAD⁺ impairs mitochondrial function, sirtuin activity, and DNA repair.

What research shows. In animal models, repleting NAD⁺ via precursors like NR or NMN restores cellular energy, improves insulin sensitivity, reduces DNA damage markers, and enhances physical function. Healthspan consistently improves in rodents, prompting human trials of NAD⁺-boosting strategies.

Glutathione: The Master Intracellular Antioxidant

What it is. GSH is a tripeptide (glu–cys–gly) and the cell’s primary redox buffer. In a healthy state, >98% exists as reduced GSH (active), maintaining a high GSH:GSSG ratio—an indicator of youthful cellular redox balance.

Core functions. GSH neutralizes reactive oxygen species (ROS) and peroxides, detoxifies xenobiotics through conjugation, and regenerates other antioxidants (e.g., vitamins C and E). Oxidized GSSG is recycled back to GSH by glutathione reductase using NADPH.

Aging relevance. GSH declines with age in many tissues, correlating with frailty and chronic disease, while some healthy centenarians maintain youthful GSH balance. Synthesis depends on precursor availability (especially cysteine) and NRF2-driven gene programs—both can be blunted with age. Early clinical work (e.g., GlyNAC—glycine + NAC) suggests restoring precursors improves oxidative stress, inflammation, mitochondrial function, and physical performance in older adults.

Why Both Matter for Healthy Aging

Aging features mitochondrial dysfunction, redox imbalance, chronic inflammation, and genomic instability. NAD⁺ and GSH address multiple hallmarks at once:

• Mitochondrial support: NAD⁺ activates sirtuins (e.g., SIRT3) to enhance mitochondrial function; GSH quenches mitochondrial ROS. Together they sustain ATP generation and protect organelles.
• Redox control: NAD⁺ enables NADPH production for GSH recycling (GSSG→GSH), while GSH directly scavenges ROS. Loss of either drives oxidative stress and inflammation.
• Genomic maintenance & detox: NAD⁺ supports PARP- and sirtuin-dependent DNA repair; GSH prevents oxidative DNA damage and clears toxic byproducts, lightening the burden on NAD⁺-consuming repair pathways.

Synergy Spotlight: How NAD⁺ and GSH Reinforce Each Other

• SIRT3–NADPH–GSH axis: Adequate NAD⁺ activates SIRT3, which boosts IDH2 activity and NADPH production, powering glutathione reductase to regenerate GSH. In mice, SIRT3 activation raises mitochondrial NADPH and GSH and reduces oxidative damage; benefits vanish when SIRT3 is absent.
• Curbing inflammation: Sirtuins (NAD⁺-dependent) dampen NF-κB signaling; GSH limits ROS-driven inflammatory cascades. If NAD⁺ falls (e.g., via CD38), GSH recycling suffers, fueling a cycle of oxidative stress and further NAD⁺ depletion.
• Mutual protection: GSH limits oxidative DNA damage and spares NAD⁺ by reducing PARP overactivation. NAD⁺ availability sustains NADPH generation, preserving GSH under stress. The result is a self-reinforcing loop of improved redox control and cellular resilience.

Research Highlights

Cells & Animal Models

• Elevating NAD⁺ or supplying GSH precursors improves stress tolerance, mitochondrial function, insulin sensitivity, and physical performance in aged rodents.
• GlyNAC extends lifespan in mice, improves mitochondrial health, lowers oxidative damage, and raises both NAD⁺ and GSH, outperforming glycine alone—supporting the case for combination strategies.

Human Data

• Observational: NAD⁺ and GSH decline with age; better maintenance correlates with stronger metabolic and functional metrics. Centenarians often show youthful GSH/GSSG ratios.
• Early trials: NR/NMN raise NAD⁺ in older adults and may modestly improve vascular and metabolic markers. GlyNAC increases GSH, reduces oxidative stress and inflammation, and improves insulin resistance and physical function. IV approaches (NAD⁺ or GSH) remain exploratory; oral precursors have the strongest evidence base so far.

Frontiers & Open Questions

• Combination (“stacking”): Do NR/NMN + NAC/glycine outperform single agents across function, inflammation, and mitochondrial endpoints? Optimal dosing/timing needs study.
• Endogenous boosting: Targeting NAMPT (NAD⁺ synthesis), CD38 (NAD⁺ degradation), GCL/GR (GSH synthesis/recycling), or NRF2 (antioxidant programs) may offer durable benefits.
• Delivery innovation: Liposomal, intranasal, and nanoparticle co-delivery systems aim to improve cellular uptake; clinical validation is pending.
• Personalization: Biomarkers (e.g., NAD⁺ levels, GSH:GSSG ratio) may guide tailored interventions as reference ranges by age and tissue are refined.

Conclusion

NAD⁺ and glutathione are foundational to cellular homeostasis—powering metabolism, stabilizing the genome, and maintaining redox balance. Their age-related decline contributes to dysfunction; conversely, supporting both together may address multiple aging mechanisms at once. While larger human trials are needed, converging evidence from basic science, animal studies, and early clinical work positions NAD⁺ + GSH as a compelling, synergistic target set for extending healthspan.

Product available for research use only:

References (2015–2025):

Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208–1213. PMID: 26785480.
Fang EF, Lautrup S, et al. NAD⁺ in aging: molecular mechanisms and translational implications. Trends Mol Med. 2017;23(10):899–916. DOI: 10.1016/j.molmed.2017.08.001.
Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD⁺-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529–547. DOI: 10.1016/j.cmet.2018.02.011.
Baur JA. Age-related NAD⁺ decline. Exp Gerontol. 2020;134:110888. DOI: 10.1016/j.exger.2020.110888. (Discusses evidence for NAD⁺ decline in tissues and mechanisms.)
Covarrubias AJ, et al. Senescent cells promote tissue NAD⁺ decline during ageing via the activation of CD38⁺ macrophages. Nat Metab. 2020;2(11):1265–1283. DOI: 10.1038/s42255-020-00305-3.
Hogan KA, Chini CCS, Chini EN. The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases. Front Immunol. 2019;10:1187. DOI: 10.3389/fimmu.2019.01187.
Peclat TR, et al. CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging. Aging Cell. 2022;21(4):e13589. DOI: 10.1111/acel.13589.
Labarrere CA, Kassab GS. Glutathione: a Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation. Front Nutr. 2022;9:1007816. DOI: 10.3389/fnut.2022.1007816.
Giustarini D, et al. How to increase cellular glutathione. Antioxidants (Basel). 2023;12(5):1094. DOI: 10.3390/antiox12051094.
Sharma A, et al. Potential synergistic supplementation of NAD⁺-promoting compounds as a strategy for increasing healthspan. Nutrients. 2023;15(2):445. DOI: 10.3390/nu15020445.
Miller RA, et al. Glycine supplementation extends lifespan of male mice. Aging Cell. 2019;18(3):e12953. DOI: 10.1111/acel.12953. (ITP study showing modest lifespan extension with glycine.)
Kumar P, et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. Clin Transl Med. 2021;11(3):e372. DOI: 10.1002/ctm2.372.
Kumar P, et al. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2023;78(1):75–89. DOI: 10.1093/gerona/glac135.
Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. DOI: 10.1126/science.abe9985.
Martens CR, et al. Chronic nicotinamide riboside supplementation elevates NAD⁺ and reduces blood pressure in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. DOI: 10.1038/s41467-018-03421-7.
Orr ME, et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 2024;46(1):665–682. DOI: 10.1007/s11357-023-00999-9.
Chini EN, Tarragó MG, Chini CCS. NAD⁺ and the aging process: role in life, death and everything in between. Mol Cell Endocrinol. 2017;455:62–74. DOI: 10.1016/j.mce.2016.11.003.
Moon JS, et al. ATP exposure stimulates glutathione efflux as a necessary switch for NLRP3 inflammasome activation. Redox Biol. 2021;41:101930. DOI: 10.1016/j.redox.2021.101930.
Iskusnykh IY, Zakharova AA, Pathak D. Glutathione in brain disorders and aging. Molecules. 2022;27(1):324. DOI: 10.3390/molecules27010324.
López-Otín C, et al. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243–278. DOI: 10.1016/j.cell.2022.11.001. (Comprehensive review updating biological hallmarks, including loss of proteostasis, mitochondrial dysfunction, etc., relevant to NAD⁺/GSH context.)